The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Targeting of drugs and nanoparticles to tumors
Open accessAbstract
The various types of cells that comprise the tumor mass all carry molecular markers that are not expressed or are expressed at much lower levels in normal cells. These differentially expressed molecules can be used as docking sites to concentrate drug conjugates and nanoparticles at tumors. Specific markers in tumor vessels are particularly well suited for targeting because molecules at the surface of blood vessels are readily accessible to circulating compounds. The increased concentration of a drug in the site of disease made possible by targeted delivery can be used to increase efficacy, reduce side effects, or achieve some of both. We review the recent advances in this delivery approach with a focus on the use of molecular markers of tumor vasculature as the primary target and nanoparticles as the delivery vehicle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Self-citationBiodegradable luminescent porous silicon nanoparticles for in vivo applications
Park, J.-H., Gu, L., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Nature Materials · doi:10.1038/nmat2398 · Cited by 1,897
Self-citationExploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Gold nanostructures: engineering their plasmonic properties for biomedical applications
Hu, M., Chen, J., Li, Z.-Y., Au, L., Hartland, G. V., Li, X., Marquez, M., & Xia, Y. (2006) · Chemical Society Reviews · doi:10.1039/b517615h · Cited by 1,756
Organ targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
Self-citationTissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
Self-citationMajor nucleolar proteins shuttle between nucleus and cytoplasm
Borer, R. A., Lehner, C. F., Eppenberger, H. M., & Nigg, E. A. (1989) · Cell · doi:10.1016/0092-8674(89)90241-9 · Cited by 1,114
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Self-citationAnti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Self-citationTumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Teesalu, T., Sugahara, K. N., Kotamraju, V. R., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908201106 · Cited by 812
Self-citationBartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Molecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Self-citationTransport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Thurber, G. M., Schmidt, M. M., & Wittrup, K. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.012 · Cited by 624
Wang, D., He, J., Rosenzweig, N., & Rosenzweig, Z. (2004) · Nano Letters · doi:10.1021/nl035010n · Cited by 589
The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform
Hong, S., Leroueil, P. R., Majoros, I. J., Orr, B. G., Baker, J. R., & Banaszak Holl, M. M. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.015 · Cited by 586
Song, S., Ewald, A. J., Stallcup, W., Werb, Z., & Bergers, G. (2005) · Nature Cell Biology · doi:10.1038/ncb1288 · Cited by 548
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
Laakkonen, P., Porkka, K., Hoffman, J. A., & Ruoslahti, E. (2002) · Nature Medicine · doi:10.1038/nm720 · Cited by 498
Self-citationNucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
Christian, S., Pilch, J., Akerman, M. E., Porkka, K., Laakkonen, P., & Ruoslahti, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304132 · Cited by 497
Self-citationVascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
Reddy, G. R., Bhojani, M. S., McConville, P., Moody, J., Moffat, B. A., Hall, D. E., Kim, G., Koo, Y.-E. L., Woolliscroft, M. J., Sugai, J. V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0946 · Cited by 491
Xu, J., Rodriguez, D., Petitclerc, E., Kim, J. J., Hangai, M., Yuen, S. M., Davis, G. E., & Brooks, P. C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103111 · Cited by 489
Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature
Huang, X., Molema, G., King, S., Watkins, L., Edgington, T. S., & Thorpe, P. E. (1997) · Science · doi:10.1126/science.275.5299.547 · Cited by 477
Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K. M., Carver, L. A., Testa, J. E., & Schnitzer, J. E. (2004) · Nature · doi:10.1038/nature02580 · Cited by 475
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 471
Self-citationKim, H., Achermann, M., Balet, L. P., Hollingsworth, J. A., & Klimov, V. I. (2005) · Journal of the American Chemical Society · doi:10.1021/ja047107x · Cited by 463
von Maltzahn, G., Centrone, A., Park, J., Ramanathan, R., Sailor, M. J., Hatton, T. A., & Bhatia, S. N. (2009) · Advanced Materials · doi:10.1002/adma.200803464 · Cited by 455
Self-citationNanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Genes that Distinguish Physiological and Pathological Angiogenesis
Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D., Graff-Cherry, C., & St. Croix, B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.017 · Cited by 419
Cell surface tumor endothelial markers are conserved in mice and humans.
Carson-Walter, E. B., Watkins, D. N., Nanda, A., Vogelstein, B., Kinzler, K. W., & Croix, B. S. (2001) · PubMed · Cited by 414
Müller, O. J., Kaul, F., Weitzman, M. D., Pasqualini, R., Arap, W., Kleinschmidt, J. A., & Trepel, M. (2003) · Nature Biotechnology · doi:10.1038/nbt856 · Cited by 410
Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display
Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., & Josephson, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060515m · Cited by 388
TAT transduction: the molecular mechanism and therapeutic prospects
Gump, J. M., & Dowdy, S. F. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.08.002 · Cited by 356
Molecular Biology and Pathology of Lymphangiogenesis
Karpanen, T., & Alitalo, K. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151515 · Cited by 356
The folate receptor: What does it promise in tissue-targeted therapeutics?
Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350
Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor Stroma
Fogal, V., Zhang, L., Krajewski, S., & Ruoslahti, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6752 · Cited by 346
Self-citationMicellar Hybrid Nanoparticles for Simultaneous Magnetofluorescent Imaging and Drug Delivery
Park, J., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801810 · Cited by 333
Self-citationAbe, K., Shoji, M., Chen, J., Bierhaus, A., Danave, I., Micko, C., Casper, K., Dillehay, D. L., Nawroth, P. P., & Rickles, F. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8663 · Cited by 312
Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library
Koivunen, E., Wang, B., & Ruoslahti, E. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.3.373 · Cited by 308
Self-citationCooperative nanomaterial system to sensitize, target, and treat tumors
Park, J.-H., von Maltzahn, G., Xu, M. J., Fogal, V., Kotamraju, V. R., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909565107 · Cited by 307
Self-citationSystematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting
Park, J., von Maltzahn, G., Zhang, L., Derfus, A. M., Simberg, D., Harris, T. J., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Small · doi:10.1002/smll.200801789 · Cited by 293
Self-citationPorkka, K., Laakkonen, P., Hoffman, J. A., Bernasconi, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062189599 · Cited by 291
Self-citationTargeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
Self-citationAntitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
Laakkonen, P., Åkerman, M. E., Biliran, H., Yang, M., Ferrer, F., Karpanen, T., Hoffman, R. M., & Ruoslahti, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403317101 · Cited by 275
Self-citationRegulation of Extravascular Coagulation by Microvascular Permeability
Dvorak, H. F., Senger, D. R., Dvorak, A. M., Harvey, V. S., & McDonagh, J. (1985) · Science · doi:10.1126/science.3975602 · Cited by 247
Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
Kelly, K. A., Bardeesy, N., Anbazhagan, R., Gurumurthy, S., Berger, J., Alencar, H., DePinho, R. A., Mahmood, U., & Weissleder, R. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050085 · Cited by 240
Wickham, T. J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301115 · Cited by 236
Nilsson, F., Kosmehl, H., Zardi, L., & Neri, D. (2001) · PubMed · Cited by 235
Targeting of albumin-embedded paclitaxel nanoparticles to tumors
Karmali, P. P., Kotamraju, V. R., Kastantin, M., Black, M., Missirlis, D., Tirrell, M., & Ruoslahti, E. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.07.007 · Cited by 234
Self-citationProgressive vascular changes in a transgenic mouse model of squamous cell carcinoma
Hoffman, J. A., Giraudo, E., Singh, M., Zhang, L., Inoue, M., Porkka, K., Hanahan, D., & Ruoslahti, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00273-3 · Cited by 224
Self-citationTEM8 Interacts with the Cleaved C5 Domain of Collagen α3(VI)
Nanda, A., Carson-Walter, E. B., Seaman, S., Barber, T. D., Stampfl, J., Singh, S., Vogelstein, B., Kinzler, K. W., & St. Croix, B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2408 · Cited by 211
Joyce, J. A., Laakkonen, P., Bernasconi, M., Bergers, G., Ruoslahti, E., & Hanahan, D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00271-x · Cited by 211
Self-citationPerspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey, R. M., & Goldenberg, D. M. (2005) · PubMed · Cited by 200
van Osdol, W. W., Fujimori, K., & Weinstein, J. N. (1991) · PubMed · Cited by 170
Simberg, D., Park, J.-H., Karmali, P. P., Zhang, W.-M., Merkulov, S., McCrae, K., Bhatia, S. N., Sailor, M., & Ruoslahti, E. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.056 · Cited by 164
Self-citationPeptides selected for binding to clotted plasma accumulate in tumor stroma and wounds
Pilch, J., Brown, D. M., Komatsu, M., Järvinen, T. A. H., Yang, M., Peters, D., Hoffman, R. M., & Ruoslahti, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511219103 · Cited by 162
Self-citationIs Anticancer Drug Development Heading in the Right Direction?
Hambley, T. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3786 · Cited by 153
Erdreich‐Epstein, A., Shimada, H., Groshen, S. G., Liu, M., Metelitsa, L. S., Kim, K., Stins, M. F., Seeger, R. C., & Durden, D. L. (2000) · PubMed · Cited by 148
Multicomponent Nanoparticles via Self-Assembly with Cross-Linked Block Copolymer Surfactants
Kim, B., & Taton, T. A. (2006) · Langmuir · doi:10.1021/la062692w · Cited by 140
Bieker, R., Keßler, T., Schwöppe, C., Padró, T., Persigehl, T., Bremer, C., Dreischalück, J., Kolkmeyer, A., Heindel, W. L., Mesters, R. M., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150318 · Cited by 139
Coupling Tumor Necrosis Factor-α with αV Integrin Ligands Improves Its Antineoplastic Activity
Curnis, F., Gasparri, A. M., Sacchi, A., Longhi, R., & Corti, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1753 · Cited by 138
A role for the NG2 proteoglycan in glioma progression
Stallcup, W. B., & Huang, F.-J. (2008) · Cell Adhesion & Migration · doi:10.4161/cam.2.3.6279 · Cited by 135
Impaired angiogenesis in aminopeptidase N-null mice
Rangel, R., Sun, Y. K., Guzman‐Rojas, L., Ozawa, M. G., Sun, J. D., Giordano, R. J., Pelt, C. S. V., Tinkey, P. T., Behringer, R. R., Sidman, R. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611653104 · Cited by 131
Paoloni, M. C., Tandle, A. T., Mazcko, C. N., Hanna, E., Kachala, S. S., LeBlanc, A. K., Newman, S. J., Vail, D. M., Henry, C. J., Thamm, D. H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004972 · Cited by 118
Henke, E., Perk, J., Vider, J., de Candia, P., Chin, Y., Solit, D. B., Ponomarev, V., Cartegni, L., Manova, K., Rosen, N. X., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1366 · Cited by 117
Protease‐Triggered Unveiling of Bioactive Nanoparticles
Harris, T. J., von Maltzahn, G., Lord, M. E., Park, J., Agrawal, A., Min, D., Sailor, M. J., & Bhatia, S. N. (2008) · Small · doi:10.1002/smll.200701319 · Cited by 117
Self-citationAntiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors
Chang, D.-K., Chiu, C., Kuo, S.-Y., Lin, W.-C., Lo, A., Wang, Y., Li, P., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900280200 · Cited by 109
Haviv, Y. S., Blackwell, J. L., Kanerva, A., Nagi, P. A., Krasnykh, V. N., Dmitriev, I. P., Wang, M., Naito, S., Lei, X., Hemminki, A., et al. (2002) · Molecular Therapy · doi:10.1016/s1525-0016(16)44194-8 · Cited by 104
Ye, F., Jeong, E., Jia, Z., Yang, T., Parker, D., & Lu, Z. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800211r · Cited by 100
Fogal, V., Sugahara, K. N., Ruoslahti, E. I., & Christian, S. (2009) · Angiogenesis · doi:10.1007/s10456-009-9137-5 · Cited by 92
Self-citationLewis, V. O., Ozawa, M. G., Deavers, M. T., Wang, G., Shintani, T., Arap, W., & Pasqualini, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4845 · Cited by 79
Molecular Changes in the Vasculature of Injured Tissues
Järvinen, T. A. H., & Ruoslahti, E. I. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061251 · Cited by 74
Self-citationIsoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif
Curnis, F., Sacchi, A., Gasparri, A. M., Longhi, R., Bachi, A., Doglioni, C., Bordignon, C., Traversari, C., Rizzardi, G., & Corti, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1272 · Cited by 71
Song, E., Wang, G., Xie, H., Zhang, Z., Hu, J., Peng, J., Wu, D., Shi, Y., & Pang, D. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.092023 · Cited by 65
Drecoll, E., Gaertner, F. C., Miederer, M., Blechert, B., Vallon, M., Müller, J. M., Alke, A., Seidl, C., Bruchertseifer, F., Morgenstern, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005715 · Cited by 58
Hamzah, J., Nelson, D. J., Moldenhauer, G., Arnold, B., Hämmerling, G. J., & Ganß, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33201 · Cited by 57
Gregorc, V., Citterio, G., Vitali, G., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.005 · Cited by 54
Mueller, J., Gaertner, F. C., Blechert, B., Janssen, K., & Essler, M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0538 · Cited by 50
New targeted probes for radioimaging of angiogenesis
Stollman, T. H., Ruers, T. J. M., Oyen, W. J. G., & Boerman, O. C. (2009) · Methods · doi:10.1016/j.ymeth.2009.03.006 · Cited by 49
Jacobson, B. S., Stolz, D. B., & Schnitzer, J. E. (1996) · Nature Medicine · doi:10.1038/nm0496-482 · Cited by 48
Collagen Targeting Using Protein-Functionalized Micelles: The Strength of Multiple Weak Interactions
Reulen, S. W. A., Dankers, P. Y. W., Bomans, P. H. H., Meijer, E. W., & Merkx, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807723p · Cited by 46
A Proteomic Approach for the Identification of Vascular Markers of Liver Metastasis
Borgia, B., Roesli, C., Fugmann, T., Schliemann, C., Cesca, M., Neri, D., & Giavazzi, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2939 · Cited by 42
Inhibition of Experimental Metastasis by Targeting the HUIV26 Cryptic Epitope in Collagen
Roth, J., Caunt, M., Cretu, A., Akalu, A., Policarpio, D., Li, X., Gagne, P. J., Formenti, S. C., & Brooks, P. C. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050176 · Cited by 29
Kranenborg, M. H. G. C., Boerman, O. C., Oosterwijk‐Wakka, J. C., de Weijert, M. C. A., Corstens, F. H. M., & Oosterwijk, E. (1998) · International Journal of Cancer · Cited by 27
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Metadata
- Authors
- Ruoslahti, E., Bhatia, S. N., & Sailor, M. J.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2010-03-15
- Volume
- 188
- Issue
- 6
- Pages
- 759-768
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2147219712
- Cited by
- 829
- References
- 98
- FWCI
- 29.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.